This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Haute Autorité de Santé. Traitement des symptômes du bas appareil urinaire liés à l'hypertrophie bénigne de la prostate par laser. [Laser treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia] Paris: Haute Autorité de Santé (HAS). 2013
To assess and compare the efficacy, the safety and the cost of the laser techniques most widely used in France (laser photoselective vaporisation of the prostate (PVP)) and overseas (Holmium laser enucleation (HoLEP)) compared with traditional techniques (transurethral resection of the prostate (TURP) and open prostatectomy (OP)).
To determine the precise indications and the conditions of use of the two laser techniques.
In summary, the literature data on one hand and the views of the consulted healthcare professionals on the other show that the studied laser techniques (PVP and HoLEP) can be regarded as possible treatment options in the same indications as the traditional techniques (TURP and OP), given the advantages shown by these two laser techniques, namely reductions in bleeding, the length of catheterisation and the length of stay in hospital.
INAHTA brief and checklist
Subject indexing assigned by CRD
Humans; Laser Therapy; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Risk Factors
Country of organisation
An English language summary is available.
Address for correspondence
French National Authority for Health, 2, avenue du Stade de France, Saint-Denis La Plaine, FR-93218 Paris France
Tel: +33 1 55 937188 Email: firstname.lastname@example.org
Date abstract record published